StocksInsight

CRS Stock vs the S&P 500: Returns, Risk and Crash History

Carpenter Technology Corporation, basic materials (market value $15.1 billion): how it compared with the S&P 500, how it behaved in every crash since 2008, its risk‑adjusted returns and what analysts said. Returns to Oct 30, 2026; analyst data as of Nov 16, 2026.

Published Updated 4 min readHow we research

What changed since Nov 9

Exent re-checks this page every day. Ratings appear 30 days after they are published; the top‑ranked analysts’ calls are not counted here, they are in Gems.

+2 new ratings88% Buy ratings (was 86%)5 4★+ analysts covering (was 6)

Key takeaways

  • CRS returned +865.6% over the 5 years to Oct 30, 2026 versus +75.9% for the S&P 500: it beat the index.
  • Its 5-year Sharpe ratio was 1.07 against 0.58 for the S&P 500.
  • Its deepest crisis drawdown was −85.0% in the global financial crisis (2007–09) (S&P 500: −56.5%).
  • Five‑year volatility was 47.3% and beta 1.43.
  • 8 analysts rated it in the past year; 88% of their latest calls were Buy.
  • CRS beat earnings estimates in 11 of its last 12 reports; the stock moved 8.0% on average, up or down, around each report.

What do the best‑ranked analysts on CRS say now? See it in Exent Gems →

Did CRS beat the S&P 500?

Over the 5 years to Oct 30, 2026, Carpenter Technology Corporation (CRS) returned +865.6% including dividends, versus +75.9% for the S&P 500 (SPY). It beat the index by 789.7 percentage points, or +57.4% a year against +12.0%.

PeriodCRSS&P 500CRS per yearS&P 500 per yearResult
1 year−10.2%+12.0%−10.2%+12.0%Lagged
3 years+357.9%+87.4%+66.1%+23.3%Beat
5 years+865.6%+75.9%+57.4%+12.0%Beat
10 years+949.4%+316.3%+26.5%+15.3%Beat
  • 1 year
    CRS
    −10.2%
    S&P 500
    +12.0%
    CRS per year
    −10.2%
    S&P 500 per year
    +12.0%
    Result
    Lagged
  • 3 years
    CRS
    +357.9%
    S&P 500
    +87.4%
    CRS per year
    +66.1%
    S&P 500 per year
    +23.3%
    Result
    Beat
  • 5 years
    CRS
    +865.6%
    S&P 500
    +75.9%
    CRS per year
    +57.4%
    S&P 500 per year
    +12.0%
    Result
    Beat
  • 10 years
    CRS
    +949.4%
    S&P 500
    +316.3%
    CRS per year
    +26.5%
    S&P 500 per year
    +15.3%
    Result
    Beat

Total return with dividends reinvested, from month-end prices to Oct 30, 2026. Beating the index on raw return is only half the story: the next section adjusts for the risk taken. See also how to beat the S&P 500.

What Wall Street analysts say about CRS

In the 12 months to 30 days ago, 8 analysts published 79 ratings on CRS. Their latest calls were 88% Buy, 13% Hold and 0% Sell. 5 of them rank 4★ or higher in Exent’s analyst scoring, which is based on each analyst’s past price‑target hit rate and returns.

The consensus 12‑month price target was $461.67 (range $450.00–$470.00), +69.9% from the last price. Remember that the average analyst’s target is hit only about half the time: how accurate are price targets?

Top‑ranked analyst coveringFirmStarsPrice‑target hit rate
??????5.0★70.5%
??????4.9★57.3%
Scott DeuschleDeutsche Bank 4.8★72.0%
Andre MadridBTIG4.8★66.3%
David E. StraussWells Fargo4.8★68.6%

Other analysts covering CRS: Bennett Moore

Ratings are shown with a 30‑day delay. Who the top‑ranked analysts on CRS are, their live calls and the median target of only the top‑rated analysts are in Exent Gems.

The average analyst’s target is reached about 53.0% of the time; Exent Gems is built on the top 50 of Exent’s ranking,where some reached 90% or more over the last two years. Unlock the top 50 analysts.

CRS returns by year vs the S&P 500

CRS beat the S&P 500 in 6 of the 9 full calendar years shown.

YearCRSS&P 500Difference
2026 (to Oct 30, 2026)−9.9%+11.7%−21.6%
2025+86.2%+17.7%+68.5%
2024+141.7%+24.9%+116.8%
2023+94.5%+26.2%+68.3%
2022+29.5%−18.2%+47.7%
2021+2.7%+28.7%−26.0%
2020−39.4%+18.3%−57.7%
2019+42.2%+31.2%+11.0%
2018−29.2%−4.6%−24.6%
2017+43.4%+21.7%+21.7%

CRS risk-adjusted returns: Sharpe, Sortino and volatility

Over 5 years, CRS had a Sharpe ratio of 1.07 against 0.58 for the S&P 500, so it earned more return per unit of risk than the index. Its annualized volatility was 51.5% and its beta 1.43: it tended to move about 1.4× as much as the market.

MetricCRSS&P 500
Annual return+57.4%+12.0%
Volatility (annualized)51.5%15.5%
Sharpe ratio1.070.58
Sortino ratio2.150.91
Max drawdown (month-end)−54.1%−23.9%
Beta to the S&P 5001.431.00

Sharpe divides return above cash by total volatility; Sortino counts only downside volatility. Both use monthly returns and the 1–3 month T‑bill ETF (BIL) as the risk‑free rate.

How CRS behaved in past crashes

CRS’s deepest fall in the crises below was −85.0% in the global financial crisis (2007–09), against −56.5% for the S&P 500. The last column turns that into money: what a $100,000 position would have lost from peak to trough.

CrisisCRSS&P 500Loss on $100,000
Global financial crisis (2007–09)−85.0%−56.5%−$84,970
2018 trade-war selloff−43.9%−20.2%−$43,850
COVID crash (Feb–Mar 2020)−66.2%−34.1%−$66,240
2022 inflation bear market−42.2%−25.4%−$42,160
2025 tariff selloff−28.1%−19.0%−$28,110
WindowCRS max drawdown
Last 1 year−56.4%
Last 3 years−56.4%
Last 5 years−56.4%
Last 10 years−75.4%

Peak‑to‑trough declines from daily prices inside each crisis window. A crash replay does not predict the next crisis; it shows how much room a holding needs. Run the same replay on a whole portfolio with the crash test.

What moves with CRS, and what doesn’t

Correlation runs from −1 (moves opposite) to +1 (moves in lockstep). Over the last 60 months of monthly returns, CRS’s correlation with the S&P 500 was 0.43, with the Nasdaq‑100 0.36, with long Treasuries (TLT) 0.29 and with gold (GLD) 0.12.

Adding a 5% CRS position to an S&P 500 portfolio would have moved its 5‑year volatility from 15.5% to 16.0%.

Least correlated large capsCorrelationMost correlated large capsCorrelation
PFE−0.16HWM0.71
CME−0.15GE0.60
INTU−0.07AXP0.55
ABBV−0.06CAT0.54
GILD−0.05BAC0.52

Holdings that are highly correlated behave like one position in a selloff. See how to find hidden overlap.

Latest CRS upgrades, downgrades and price‑target changes

DateRating and targetAnalyst
Oct 23Target cut
Buy
Target $470, was $620
Andre Madrid
BTIG
Oct 14Target cut
Buy
Target $520, was $700
Bennett Moore
J.P. Morgan
Oct 8Target cut
Buy
Target $465, was $608
Samuel McKinney
KeyBanc
Sep 30Target cut
Hold
Target $430, was $540
David E. Strauss
Wells Fargo

Named analysts’ rating and price‑target changes on CRS in the 5 weeks to Oct 20, 2026, shown 30 days after publication (the free analysts’ calls 3 days after). The top‑ranked analysts’ calls are in Exent Gems. See all of the latest analyst upgrades and downgrades.

Do analysts get CRS right?

Of the 89 analyst price targets on CRS set from 2019 until a year ago, 97.8% were reached within 12 months (data to Oct 20, 2026), 29.2 points above the 68.6% hit rate of the median stock in Exent’s study of 794 stocks. Targets that were reached took a median of 95 days. The median target sat 21.7% above the share price on the day it was set.

Where analysts said CRS would be by now: a year ago, 5 analysts had a price target on CRS, and the median of their latest targets was $388.00. On Oct 20, 2026 CRS closed at $372.71, 3.9% below it.

97.8%of targets reached within 12 monthsMedian stock: 68.6%
95 daysmedian time to reach a target
−3.9%price now vs the median target set a year ago

How CRS moves after earnings

CRS beat the consensus earnings‑per‑share estimate in 11 of its last 12 quarterly reports, through the one on Jul 30, 2026, and the revenue estimate in 4 of 12. From the close before each report to the close after it, the stock moved 8.0% on average, up or down, against 6.8% for the average report across the 1,002 US stocks Exent tracks. It rose after 5 of the 12 reports. In 5 of the 11 beats the stock still fell.

11/12earnings beats
±8.0%average move per report
5/12reports followed by a rise
ReportEPS vs estimateRevenue vs estimateStock move
Jul 30, 2026$3.23 vs $3.09−1.4%−2.1%
Apr 29, 2026$2.77 vs $2.63+1.8%0.0%
Jan 29, 2026$2.33 vs $2.22+5.4%−4.2%
Oct 23, 2025$2.43 vs $2.13+2.2%+28.4%
Jul 31, 2025$2.21 vs $2.07−4.7%−9.1%
Apr 24, 2025$1.88 vs $1.74−0.4%+4.3%
Jan 30, 2025$1.66 vs $1.56−6.5%−7.7%
Oct 24, 2024$1.73 vs $1.58−3.4%−0.8%

Reported earnings per share against the consensus estimate, revenue surprise in percent, and the stock’s price change over the two sessions around the report. How stocks move after earnings

Where CRS’s revenue comes from

In fiscal 2026 (the year to Jun 30, 2026), CRS’s largest reported region was the United States, with 58.4% of its $3.1 billion revenue. By region: United States 58.4%; Europe 22.4%; Asia Pacific 10.9%; Mexico 4.5%.

By business, the largest segment was Aerospace And Defense Markets, with 65.1% of $3.1 billion revenue (+15.1% on the year before).

  • United States58.4%
  • Europe22.4%
  • Asia Pacific10.9%
  • Mexico4.5%
  • Canada2.0%
  • Other Country1.7%
SegmentRevenueShareGrowth
Aerospace And Defense Markets$2.0 billion65.1%+15.1%
Industrial And Consumer Markets$401.8 million12.9%+11.8%
Medical Market$278.4 million8.9%−20.7%
Energy Market$230.6 million7.4%+15.1%
Transportation Market$100.4 million3.2%−11.4%
Distribution Market$77.8 million2.5%−7.6%

From CRS’s annual filings; segment growth compares fiscal 2026 with the year before. Regions are as each company reports them, so one company’s “Asia Pacific” is not another’s. China counts the regions a company reports as China, Greater China or Hong Kong; a separately reported Taiwan is not counted. Which S&P 500 companies depend most on China?

Members of Congress who traded CRS

As of Oct 20, 2026, 1 member of Congress had disclosed 3 trades in CRS (3 buys and 0 sales) in STOCK Act disclosures filed with the House and Senate. The latest public trade is dated Feb 4, 2026.

Trade dateMemberTypeAmount
Feb 4, 2026Markwayne MullinBuy$15,001–$50,000
Jan 5, 2026Markwayne MullinBuy$15,001–$50,000
Jan 5, 2026Markwayne MullinBuy$15,001–$50,000

Amounts are the ranges members report, not exact values. The STOCK Act gives members up to 45 days to disclose a trade, so trades appear weeks after they are made. See every member’s disclosed trades

Are CRS insiders buying or selling?

In the 12 months to Oct 20, 2026, CRS insiders made no open‑market purchases and 38 sales worth $93.6 million, according to SEC Form 4 filings. The last open‑market purchase on record was on Mar 26, 2020.

After the 11 insider purchases of $10,000 or more since 2012, CRS beat the S&P 500 by an average of 42.5 percentage points over the next 12 months; 82% of them were followed by a beat. Across all 17,865 insider purchases in Exent’s study, the average was +17.2% and the median +1.0% against the index.

Q1 ’25
Q2 ’25
Q3 ’25
Q4 ’25
Q1 ’26
Q2 ’26
Q3 ’26
Q4 ’26
DateInsiderRoleValue
Mar 26, 2020Ligocki KathleenDirector$179,025
Mar 24, 2020Lain TimothyVP and Chief Financial Officer$59,085
Mar 18, 2020Thene Tony RDirector, officer: President and CEO$97,460
Mar 18, 2020Malloy Brian JVP - Chief Commercial Officer$49,980
Mar 18, 2020Dee James DVP, Gen Counsel & Secretary$52,890

The table lists the latest open‑market purchases on record, leaving out the last 30 days. The chart counts Form 4 purchases and sales by calendar quarter. Purchases are open‑market buys; sales include planned sales under 10b5‑1 trading plans. Do insider buys beat the market?

How much of CRS is sold short?

As of the Sep 30, 2026 settlement date, 2.99% of CRS’s float was sold short: 1.4 million shares, or 1.8 days of average trading volume to cover. A year earlier (Oct 15, 2025) it was 6.47%. The median across the 997 US stocks Exent tracks was 4.77%, so CRS is less heavily shorted than most.

  • Apr 30, 20263.54%
  • May 29, 20263.63%
  • Jun 30, 20263.54%
  • Jul 31, 20265.06%
  • Aug 31, 20263.12%
  • Sep 30, 20262.99%

From FINRA short‑interest reports, filed twice a month; the bars show the short share of the float at each month‑end. Days to cover divides the shares short by the average daily volume. The most shorted stocks

How many institutions own CRS?

At the end of Q2 2026 (Jun 30, 2026), 910 institutions reported holding CRS in 13F filings, up 182 from the quarter before and up from 609 a year earlier. Their reported holdings add up to 94.3% of CRS’s shares. In the quarter 554 institutions added to their positions and 257 cut them.

91013F holders
238new positions
56positions closed
94.3%of shares held by 13F filers

Investment managers with over $100 million in US equities file 13F reports within 45 days of each quarter end, so this is the latest complete quarter. Holdings can add up to more than 100% when shares are lent and counted twice. Which stocks institutions are buying and selling

Is CRS diluting shareholders?

CRS’s diluted share count rose 4.3% over the five fiscal years to fiscal 2026 and fell 0.6% in fiscal 2026 alone. Each share now owns a smaller slice of the company. The median change across the 1,005 US stocks Exent tracks was −0.1%.

Stock‑based compensation was $26.4 million in fiscal 2026, 0.8% of revenue. CRS spent $179.1 million buying back shares, a buyback yield of 0.80% of its market value; stock pay equaled 14.7% of the buybacks.

−0.6%share count, 1 year
+4.3%share count, 5 years
0.8%stock pay as % of revenue
0.80%buyback yield

Weighted‑average diluted shares from CRS’s annual income statements; stock‑based compensation and buybacks from its cash‑flow statement. Stock dilution and stock‑based compensation, explained

CRS financial health scores

In Exent’s Oct 20, 2026 snapshot, CRS’s Altman Z‑score was 9.49, in the safe zone (where 465 of the 794 non‑financial US stocks Exent tracks sit). Its Piotroski F‑score was 9 out of 9; 3% of scored stocks reach 9 or more.

9.49Altman Z‑score: safe zone
9/9Piotroski F‑score

The Altman Z‑score combines five balance‑sheet and earnings ratios into one bankruptcy‑risk score: below 1.81 is the distress zone, 1.81–2.99 grey, above 2.99 safe. It is not meaningful for banks, insurers and REITs. The Piotroski F‑score counts nine yes/no tests of profitability, leverage and efficiency; 8–9 is strong, 0–2 weak. Both come from the latest annual statements. Which stocks have the highest bankruptcy risk?

Which ETFs hold CRS?

As of Oct 20, 2026, 39 of the 304 ETFs Exent tracks held CRS. Its largest weight is in XAR (State Street SPDR S&P Aerospace & Defense ETF), at 2.57% of the fund.

ETFFundWeight of CRS
XARState Street SPDR S&P Aerospace & Defense ETF2.57%
ITAiShares U.S. Aerospace & Defense ETF1.44%
PAVEGlobal X U.S. Infrastructure Development ETF1.13%
PPAInvesco Aerospace & Defense ETF1.06%
IJKiShares S&P Mid-Cap 400 Growth ETF0.93%
IJHiShares Core S&P Mid-Cap ETF0.56%
SPMDState Street SPDR Portfolio S&P 400 Mid Cap ETF0.55%
MDYState Street SPDR S&P MIDCAP 400 ETF Trust0.55%

Owning several of these funds stacks the same position. How much do VOO, QQQ and VTI overlap?

The right benchmark for CRS

Exent matches every holding to the index with the most similar risk. For CRS that is SPY (the S&P 500). Comparing a holding with an index that carries very different risk makes good results look bad and risky ones look clever. Read why the S&P 500 is the wrong benchmark for most portfolios.

Other basic materials stocks

TickerName5‑year returnVolatility (5y)
SCCOSouthern Copper Corporation+297.0%39.3%
NEMNewmont Corporation+126.5%37.8%
FCXFreeport-McMoRan Inc.+77.5%45.1%
CDECoeur Mining, Inc.+107.3%69.3%
CSLCarlisle Companies Incorporated+78.4%32.9%
RPMRPM International Inc.+29.0%26.4%
MASMasco Corporation+35.1%29.7%
AXTAAxalta Coating Systems Ltd.+9.2%31.1%

Data and methodology

Returns are total returns from month‑end adjusted closing prices (dividends reinvested) through Oct 30, 2026. Crisis drawdowns and trailing maximum drawdowns use daily prices. Analyst coverage counts ratings published in the last 12 months, shown with a 30‑day delay. Full method: Exent methodology.

Company data as of Oct 20, 2026. The move around an earnings report runs from the close before it to the close after it; a price target counts as hit when the stock closed at or beyond it within 12 months (Exent analyst data). Revenue by region and segment, share counts and executive pay come from company filings; insider trades from SEC Form 4, short interest from FINRA, institutional ownership from 13F filings, Congress trades from STOCK Act disclosures filed with the House and Senate, federal contracts from USAspending.gov. Filings from the last 30 days are shown as counts only.

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Check CRS with Exent Gems

Wall Street’s average CRS price target is 69.9% above the latest share price. See what the best‑ranked analysts on CRS say now in Exent Gems.

  1. Exent ranks Wall Street analysts by their past price‑target hit rate and returns, and keeps the best‑ranked few.
  2. Gems shows who the top‑ranked analysts covering CRS are, their live calls and the median target of only the top‑rated analysts.
  3. Gems flags the stocks where several top‑ranked analysts agree: a starting point for your own research, not a promise.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

Yes. CRS returned +949.4% (+26.5% a year) over the 10 years to Oct 30, 2026, versus +316.3% (+15.3% a year) for the S&P 500, including dividends.

No. As of Oct 20, 2026, CRS (Carpenter Technology Corporation) is not one of the 503 stocks in the S&P 500.

CRS fell −85.0% from peak to trough during the global financial crisis (2007–09), versus −56.5% for the S&P 500.

CRS fell −66.2% from peak to trough during the covid crash (feb–mar 2020), versus −34.1% for the S&P 500.

CRS fell −42.2% from peak to trough during the 2022 inflation bear market, versus −25.4% for the S&P 500.

Over the 5 years to Oct 30, 2026, CRS’s Sharpe ratio was 1.07 and its Sortino ratio 2.15, versus 0.58 and 0.91 for the S&P 500.

CRS’s 5‑year annualized volatility was 47.3%, higher than the S&P 500’s 17.0%, with a beta of 1.43.

Among large US stocks, the lowest correlations with CRS over the last 60 months were PFE (−0.16), CME (−0.15), INTU (−0.07). Its correlation with long Treasuries (TLT) was 0.29 and with gold (GLD) 0.12.

CRS beat the consensus earnings-per-share estimate in 11 of its last 12 quarterly reports through Jul 30, 2026, and the revenue estimate in 4 of 12. The stock moved 8.0% on average, up or down, from the close before each report to the close after it.

Yes. As of Oct 20, 2026, 1 member of Congress had disclosed 3 trades in CRS (3 buys and 0 sales) in STOCK Act disclosures filed with the House and Senate.

As of the Sep 30, 2026 settlement date, 2.99% of CRS’s float was sold short (1.4 million shares, 1.8 days to cover), according to FINRA short-interest reports. A year earlier it was 6.47%.

Yes. CRS’s diluted share count rose 4.3% over the five fiscal years to fiscal 2026 and fell 0.6% in the latest year. Stock-based compensation was 0.8% of revenue, and buybacks totaled $179.1 million.

What do the best‑ranked analysts say on CRS now?

Exent ranks Wall Street analysts by their track record. Gems shows who the top‑ranked analysts on CRS are, their latest calls and the stocks where several of them agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.